Caspian Journal of Internal Medicine
Babol University of Medical Sciences
Thu, Dec 26, 2024
[Archive]
Volume 11 - Covid 19 Supplement 1
Caspian J Intern Med 2020, 11 - Covid 19 Supplement 1: 460-465 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Eftekhar S P, Kazemi S, Moghadamnia A A. A brief review of the latest pharmacological treatments of COVID-19. Caspian J Intern Med 2020; 11 :460-465
URL: http://caspjim.com/article-1-2287-en.html
URL: http://caspjim.com/article-1-2287-en.html
Student research committee, Health Research Center, Babol University of Medical Sciences, Babol, Iran , parsa.eftekhar@yahoo.com
Abstract: (4108 Views)
New Coronavirus which is called 2019-nCoV (2019-Novel-Coronavirus) or SARS-Cov-2 (Severe Acute respiratory Syndrome-Coronavirus 2) causes deadly pneumonia that first appeared in December 2019 in Wuhan city in China. This virus spreads all over the world quickly and made several problems for the community and healthcare system. Several drugs have been tried to manage COVID-19; however, our knowledge of this virus is not complete. At any rate, effective treatment or vaccine for this disease has not been discovered yet. Furthermore, to achieve this goal, more studies are needed on the structure of the virus and its pathogenesis mechanism. In this article, we summarized several articles suggesting treatments of COVID-19.
Type of Study: Review Article |
Subject:
pharmacology
Received: 2020/04/15 | Accepted: 2020/06/20 | Published: 2020/10/19
Received: 2020/04/15 | Accepted: 2020/06/20 | Published: 2020/10/19
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
